Federal housing agency will not cut Fannie Mae and Freddie Mac loan limits, new director says

Federal housing agency will not cut Fannie Mae and Freddie Mac loan limits, new director says


A sign for Freddie Mac is seen at their corporate headquarters campus on Oct. 9, 2024 in Tysons Corner, Virginia. 

Kevin Dietsch | Getty Images

The newly confirmed director of the Federal Housing Finance Agency, Bill Pulte, who now oversees mortgage giants Fannie Mae and Freddie Mac, said he will not lower the conforming loan limit, or the maximum value for the loans the two firms will buy and guarantee.

That limit is calculated each year according to current home prices. It now stands at $806,500, an increase of $39,950 (or 5.2%) from 2024.

“There are no plans to do anything as it relates to the conforming loan limit,” Pulte said Tuesday.

The Trump administration has touted plans to reduce the federal government, and many have expected it will work to shrink the size of Fannie Mae and Freddie Mac. The mortgage giants guarantee the vast majority of the nation’s $12 trillion mortgage market.

The FHFA has overseen the two since they went into conservatorship in 2008. With the recent appointment of Pulte, questions have been swirling about what he intends to do with two, including if he would move to lower their conforming loan limits. Pulte toured Fannie Mae and Freddie Mac offices last week, posting on social media a video of empty offices, desks and even the cafeteria.

In a recent report, the CATO Institute, a Washington, D.C.-based think tank, pushed the idea that Congress should limit the FHA’s single-family insurance portfolio to first-time homebuyers.

“Additionally, the FHA should decrease the value of loan limits eligible for FHA single-family mortgage insurance to (at most) the first quartile of home prices,” the report said.



Source

FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More
Toyota, Hyundai and Chinese automakers expected to be most impacted by Iran war
Business

Toyota, Hyundai and Chinese automakers expected to be most impacted by Iran war

Toyota Motor Corp. vehicles bound for shipment at the Port of Nagoya in Tokai, Aichi Prefecture, Japan, on Tuesday, April 29, 2025. Toru Hanai | Bloomberg | Getty Images DETROIT — Toyota Motor, Hyundai Motor and Chinese automakers such as Chery face the most potential impact of non-domestic automakers from the U.S.-Israel war with Iran, […]

Read More